Referencias

1. Turner D, Ricciuto A, Lewis A, et al; International Organization for the Study of IBD. STRIDE- II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology. 2021;160(5):1570- 1583..
2. Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114(3):384-413.
3. Maaser C, Sturm A, Vavricka SR, et al. ECCOESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13(2):144-164.
4. Shah SC, Colombel JF, Sands BE, Narula N. Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14(9): 1245-1255.e8.
5. Barreiro-de Acosta M, Vallejo N, de la Iglesia D, et al. Evaluation of the risk of relapse in ulcerative colitis according to the degree of mucosal healing (Mayo 0 vs 1): a longitudinal cohort study. J Crohns Colitis. 2016;10(1):13-19.
6. Boal Carvalho P, Dias de Castro F, Rosa B, Moreira MJ, Cotter J. Mucosal healing in ulcerative colitis – when zero is better. J Crohns Colitis. 2016;10(1):20-25.
7. Peyrin-Biroulet L, Bressenot A, Kampman W. Histologic remission: the ultimate therapeutic goal in ulcerative colitis? Clin Gastroenterol Hepatol. 2014;12(6):929-34.e2.
8. Cohen R, Skup M, Ozbay AB, et al. Direct and indirect healthcare resource utilization and cost associates with ulcerative colitis in a privately-insured employed population in the US. J Med Econ. 2015;18(6):447-456.
9. Rowe WA, Anand BS. Inflamatory bowel disease. Medscape website. https://emedicine. medscape.com/article/179037-overview#a6. Published April 10,2020.
10. Crosn ́s & Colitis Foundation. About Crohn ́s disease and ulcerative colitis. http//www. crohnscolitisfoundation.org/sites/default/files/legacy/assets/pdfs/IBDoverview.pdf. Published June 2018. Accesed June 9,2021.
11. Khan HM, Mehmood F, Khan N. Optimal Management of steroid-dependent ulcerative colitis. Clin Exp Gastroenterol. 2015;8:293-302.
12. Piercy J, Ozbay AB, Roughley A, Chao J, Skup M. Comparison of ulcerative colitis with Crohn ́s disease from the perspective of patient burden. Poster presented at: Digestive Disease Week; May 17-19,2015; Washington, DC, Poster Tu1256.
13. Ye X, Wang HHX, et al. Can fecal calprotein accurately identify histological activity of ulcerative colitis? A meta-análisis. Therap Adv Gastroenterol. 2021;14:1756284821994741. doi:10.1177/1756284821994741
14. Agrawal M, Spencer EA, Colombel JF, Ungaro RC. Approach to teh Management of recently diagnosed inflammatory bowel disease patients: a user ́s guide for adult and pediatric gastorentorologist. Gastroenterology. 2021;161(1):47-65. doi:10.1053/gastro.20221.04.063